Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 101–200 of 1,003
Animal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391
Microglia Priming with Aging and Stress
Niraula, A., Sheridan, J. F., & Godbout, J. P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.185 · Cited by 398
Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage
Taylor, R. A., & Sansing, L. H. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/746068 · Cited by 394
“When it is membrane-bound, neuronal CX3CL1 binds to microglial CX3CR1 and maintains microglia in a quiescent state [64, 65].”
BackgroundHoshiko, M., Arnoux, I., Avignone, E., Yamamoto, N., & Audinat, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1167-12.2012 · Cited by 384
“This chemokine is expressed by neurons; its receptor CX3CR1 is only expressed by MGCs and controls their migration and functions (Harrison et al., 1998; Maciejewski-Lenoir et al., 1999; Cardona et al., 2006; Ruitenberg et al., 2008; Liang et al., 2009; Paolicelli et al., 2011).”
BackgroundJimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383
“…reported that aging and/or A could decrease the neuronal expression of microglial inhibitory factors, such as CD200, fractalkine or neurotransmitters (Acetylcholine or noradrenaline) (Cardona et al., 2006; Chitnis et al., 2007; Heneka and O’Banion, 2007; Lyons et al., 2007a; Duan et al., 2008).”
BackgroundBrain Pericytes As Mediators of Neuroinflammation
Rustenhoven, J., Jansson, D., Smyth, L. C., & Dragunow, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.001 · Cited by 371
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Ransohoff, R. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.010 · Cited by 371
“Evaluation of several pathological processes which did not involve BBB compromise (and therefore did not entail large scale entry of peripheral leukocytes) showed that signaling through the fractalkine receptor reduced neuronal damage (Cardona et al., 2006).”
BackgroundSelf-citationLevesque, S., Taetzsch, T., Lull, M. E., Kodavanti, U., Stadler, K., Wagner, A., Johnson, J. A., Duke, L., Kodavanti, P., Surace, M. J., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002986 · Cited by 371
“Fractalkine is a chemokine produced by neurons that is cleaved to become a soluble anti inflammatory signal for microglia (Cardona et al. 2006).”
BackgroundFractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats
Bachstetter, A. D., Morganti, J. M., Jernberg, J., Schlunk, A., Mitchell, S. H., Brewster, K. W., Hudson, C. E., Cole, M. J., Harrison, J. K., Bickford, P. C., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.022 · Cited by 364
Neurogenesis, inflammation and behavior
Kohman, R. A., & Rhodes, J. S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.09.003 · Cited by 361
“The chemokine, fractalkine, is a neuroimmune regulatory molecule released by neurons that acts on CX3CL1 receptors (CX3CR1) localized on microglial cells and maintains microglia in their resting phenotype (Cardona et al., 2006; Harrison et al., 1998).”
BackgroundFactors regulating microglia activation
Kierdorf, K., & Prinz, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00044 · Cited by 360
Getts, D. R., Terry, R. L., Getts, M. T., Müller, M., Rana, S., Shrestha, B., Radford, J., Van Rooijen, N., Campbell, I. L., & King, N. J. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080421 · Cited by 360
Varvel, N. H., Neher, J. J., Bosch, A., Wang, W., Ransohoff, R. M., Miller, R. J., & Dingledine, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604263113 · Cited by 357
“Four days after SE, the mice were perfused with Hanks’ buffered salt solution, the brains were removed, and mononuclear cells were separated with a 30%/70% Percoll gradient as previously reported (69, 70).”
MethodSelf-citationMicroglia and ischemic stroke: a double-edged sword.
Patel, A. R., Ritzel, R. M., McCullough, L. D., & Liu, F. (2013) · Europe PMC (PubMed Central) · Cited by 406
Microglia in ALS: The Good, The Bad, and The Resting
Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353
“Furthermore, CX3CR1 has been identified as a regulator of microglial neurotoxicity in vivo (Cardona et al. 2006).”
BackgroundGonzález, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352
Gyoneva, S., & Ransohoff, R. M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.003 · Cited by 345
“First, CX3CR1 regulates microglial toxicity in the lipopolysaccharide model of neuroinflammation and in neurodegeneration models of AD, Parkinson’s disease and amyotrophic lateral sclerosis [80, 81], all of which have also been linked to TBI incidence.”
BackgroundSelf-citationMizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., & Cardona, A. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100421 · Cited by 346
“Although microglial functions are intended to be protective, it is documented that dysregulated microglial responses lead to neurotoxicity in vitro and in vivo (12).”
InfluentialSelf-citationMicroglia Phenotypes in Aging and Neurodegenerative Diseases
Wendimu, M. Y., & Hooks, S. B. (2022) · Cells · doi:10.3390/cells11132091 · Cited by 336
Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 337
“[92] made use of the CX3CR1 GFP/GFP receptor knockout mouse to study the role of FKN and CX3CR1 signalling in several models of microglial-induced neurotoxicity.”
MethodTakeshita, Y., & Ransohoff, R. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01127.x · Cited by 325
Self-citationThe multifaceted profile of activated microglia
Lynch, M. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8077-9 · Cited by 268
“It has also been reported that the neurotoxic effect of activated microglia on cultures of hippocampal neurons was enhanced by the addition of an anti-fractalkine antibody [224], while neuronal cell loss was reported following systemic administration of LPS in CX3CR1-deficient mice and exacerbated neuronal cell loss w…”
BackgroundEvidence for synaptic stripping by cortical microglia
Trapp, B. D., Wujek, J. R., Criste, G. A., Jalabi, W., Yin, X., Kidd, G. J., Stohlman, S., & Ransohoff, R. (2007) · Glia · doi:10.1002/glia.20462 · Cited by 322
“Microglia lacking the chemokine receptor, CX3CR1, can be neurotoxic in vivo (Cardona et al., 2006).”
BackgroundSelf-citationNeuroplastic changes in depression: A role for the immune system
Eyre, H., & Baune, B. T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.019 · Cited by 319
“The mechanism of this suppression is linked to the CD200 glycoprotein and the CX3CR1 receptor which both deliver an inhibitory signal to the microglia (Hoek et al., 2000; Cardona et al., 2006).”
Microglial clearance function in health and disease
Napoli, I., & Neumann, H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.046 · Cited by 313
Microglia, seen from the CX3CR1 angle
Wolf, Y., Yona, S., Kim, K.-W., & Jung, S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00026 · Cited by 316
“In rodent models of LPS-induced neuroinflammation, PD and ALS, CX3CR1-deficient microglia were found to overexpress IL-1β and display neurotoxic activity (Cardona et al., 2006).”
BackgroundSelf-citationSennlaub, F., Auvynet, C., Calippe, B., Lavalette, S., Poupel, L., Hu, S. J., Dominguez, E., Camelo, S., Levy, O., Guyon, E., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302692 · Cited by 314
“Others and we have shown that Cx3cr1 de fi ciency leads to accumulation of MPs in the central nervous system in pathological conditions (Cardona et al, 2006; Chinnery et al, 2011; Combadiere et al, 2007; Kezic et al, 2013).”
InfluentialPonomarev, E. D., Veremeyko, T., & Weiner, H. L. (2013) · Glia · doi:10.1002/glia.22363 · Cited by 284
“Similar results were observed in mice deficient in the Fractalkine receptor CX3CR1 (Cardona et al., 2006).”
ResultInfluentialImmune Regulation in the Aging Retina
Chen, M., Luo, C., Zhao, J., Devarajan, G., & Xu, H. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.10.003 · Cited by 305
“Microglial activation is regulated by various signals from retinal neurons, such as the chemokine CX3CL1 (fractalkine) (A. E. Cardona et al., 2006, Mizuno et al., 2003, Raoul, Keller et al., 2008), TGF-β (Paglinawan et al., 2003), endocannabinoids (Battista et al., 2006, Hernangomez et al., 2014,…”
Leighton, S. P., Nerurkar, L., Krishnadas, R., Johnman, C., Graham, G. J., & Cavanagh, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.205 · Cited by 291
Functional classification of memory CD8+ T cells by CX3CR1 expression
Böttcher, J. P., Beyer, M., Meissner, F., Abdullah, Z., Sander, J., Höchst, B., Eickhoff, S., Rieckmann, J. C., Russo, C., Bauer, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms9306 · Cited by 302
Self-citationCellular infiltration in traumatic brain injury
Alam, A., Thelin, E. P., Tajsic, T., Khan, D. Z., Khellaf, A., Patani, R., & Helmy, A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02005-x · Cited by 297
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Hemonnot, A.-L., Hua, J., Ulmann, L., & Hirbec, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00233 · Cited by 298
Microglia–Neuron Communication in Epilepsy
Eyo, U. B., Murugan, M., & Wu, L. (2017) · Glia · doi:10.1002/glia.23006 · Cited by 296
“They are thus critical in the early wiring of the CNS (Squarzoni et al., 2014; Zhan et al., 2014).”
BackgroundInfluentialNeuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
“The CX3CL1/CX3CR1 signaling pathway is crucial in deactivating microglia and inhibiting the release of proinflammatory cytokines (Cardona et al., 2006; Biber et al., 2007; Ginhoux et al., 2010).”
BackgroundAn ADIOL-ERβ-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation
Saijo, K., Collier, J. G., Li, A. C., Katzenellenbogen, J. A., & Glass, C. K. (2011) · Cell · doi:10.1016/j.cell.2011.03.050 · Cited by 290
“Under normal conditions, microglia are maintained in a quiescent state by neuron and astrocytederived factors (Cardona et al., 2006), and constantly survey the surrounding environment through an extensive array of ramified processes (Nimmerjahn et al.”
Avignone, E., Ulmann, L., Levavasseur, F., Rassendren, F., & Audinat, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1820-08.2008 · Cited by 287
“Activation of microglia after kainate-induced SE As previously reported for the CX3CR1 eGFP/ mouse line (Cardona et al., 2006), GFP colocalized with the specific marker of microglia Iba1 (Fig.”
BackgroundMethodInfluentialCan the immune system be harnessed to repair the CNS?
Popovich, P. G., & Longbrake, E. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2398 · Cited by 284
“In the absence of this ligand–receptor interaction, which occurs when neurons die or are damaged, microglia become hyper-responsive to stimuli and cause neurodegeneration and neurological impairmen”
BackgroundMicroglial phenotypes in Parkinson’s disease and animal models of the disease
Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285
“Interestingly, such increase of inflammatory cytokines was followed by a delayed upregulation of the microglial receptor CX3CR1 for the chemokine fractalkine CX3CL, presumably as a compensatory mechanism to limit neuronal damage and decrease levels of CX3CL (Cardona et al., 2006; Pattarini et al., 2007).”
BackgroundMacrophage subsets and microglia in multiple sclerosis
Bogie, J. F. J., Stinissen, P., & Hendriks, J. J. A. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1310-2 · Cited by 251
Arcuri, C., Mecca, C., Bianchi, R., Giambanco, I., & Donato, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00191 · Cited by 279
“Among “eat-me” signals there is the exposure of PS on neurons following oxidative stress, increase in Ca2+ levels or ATP depletion; PS binds VNRs through the interaction with MFG-E8.”
BackgroundInfluentialIn vivo structure/function and expression analysis of the CX3C chemokine fractalkine
Kim, K.-W., Vallon-Eberhard, A., Zigmond, E., Farache, J., Shezen, E., Shakhar, G., Ludwig, A., Lira, S. A., & Jung, S. (2011) · Blood · doi:10.1182/blood-2011-04-348946 · Cited by 277
Self-citationMicroglia Activation as a Biomarker for Traumatic Brain Injury
Hernandez-Ontiveros, D. G., Tajiri, N., Acosta, S., Giunta, B., Tan, J., & Borlongan, C. V. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00030 · Cited by 277
“In vitro and in vivo models of neurological conditions and brain inflammation also reported how CX3CL1 reduces microglia toxicity and, consequently, neuronal damage (Zujovic et al., 2000; Mizuno et al., 2003; Cardona et al., 2006; Bhaskar et al., 2010; Noda et al., 2011; Pabon et al., 2011).”
BackgroundLiu, Z., Condello, C., Schain, A., Harb, R., & Grutzendler, J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-10.2010 · Cited by 275
“Microglia have been shown to exacerbate neuronal death mainly in acute and subacute injury models in which they are fully activated (Wu et al., 2000; Cardona et al., 2006; Block et al., 2007).”
BackgroundInfluentialProtective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 275
“In contrast, M2 produce high levels of antiinflammatory cytokines and neurotrophic factors including IL-4, IL-10, and insulin-like growth factor (IGF)-1 in addition other neruoprotection signals such as CD200 and fractalkine [51, 60, 64–68].”
BackgroundDénes, Á., Ferenczi, S., Halász, J., Környei, Z., & Kovács, K. J. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.64 · Cited by 276
“After activation by LPS, microglia derived from CX3CR1 / mice expressed more Journal of Cerebral Blood Flow & Metabolism (2008) 28, 1707–1721 IL-1b, and adoptive transfer of these cells resulted in increased neuronal death, which was blocked by IL1Ra (Cardona et al, 2006).”
BackgroundMethodResultInfluentialIschemic neurons recruit natural killer cells that accelerate brain infarction
Gan, Y., Liu, Q., Wu, W., Yin, J.-X., Bai, X.-F., Shen, R., Wang, Y., Chen, J., La Cava, A., Poursine-Laurent, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315943111 · Cited by 273
TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage
Taylor, R. A., Chang, C.-F., Goods, B. A., Hammond, M. D., Grory, B. M., Ai, Y., Steinschneider, A. F., Renfroe, S. C., Askenase, M. H., McCullough, L. D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88647 · Cited by 274
“Consistent with the reduction in TGF-β1 signaling during the recovery phase, the CX3CR1-null BM chimeras exhibited a right forelimb preference, showing a left hemiparesis, impaired disease, CX3CR1-null mice have worse functional outcomes and elevated levels of IL-1β after LPS-mediated neuroinflammation (30, 31).”
BackgroundNeuroprotective function for ramified microglia in hippocampal excitotoxicity
Vinet, J., van Weering, H. R., Heinrich, A., Kälin, R. E., Wegner, A., Brouwer, N., Heppner, F. L., van Rooijen, N., Boddeke, H. W., & Biber, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-27 · Cited by 274
“However, microglial neurotoxicity can occur in case of overshooting and uncontrolled stimulation of microglia [3,17] or when microglia function is impaired [15,18,19].”
BackgroundIntegrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Fujita, K. A., Ostaszewski, M., Matsuoka, Y., Ghosh, S., Glaab, E., Trefois, C., Crespo, I., Perumal, T. M., Jurkowski, W., Antony, P. M. A., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8489-4 · Cited by 273
“their products inhibit microglia activation by binding to specific microglial receptors [173–177].”
BackgroundMicroglia in ischemic brain injury
Weinstein, J. R., Koerner, I. P., & Möller, T. (2009) · Future Neurology · doi:10.2217/fnl.10.1 · Cited by 272
“Absence of its receptor (CX3CR1) on microglia exacerbates microglial activation and neurotoxicity in neurodegenerative diseases, including Parkinson's disease and amyotrophic lateral sclerosis [60].”
BackgroundGlial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271
“Disruptions to CX3CR1 can increase neurotoxicity, delay synapse maturation in the hippocampus, and result in social interaction deficits (Cardona et al, 2006; Paolicelli et al, 2011; Zhan et al, 2014).”
BackgroundThe Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
Pawelec, P., Ziemka-Nalecz, M., Sypecka, J., & Zalewska, T. (2020) · Cells · doi:10.3390/cells9102277 · Cited by 269
“Recent advances in this field suggest that CX3CL1/CX3CR1 signal disruption is one of the most important elements in the pathogenesis of CNS-related disorders [21,25,26].”
BackgroundCho, S.-H., Sun, B., Zhou, Y., Kauppinen, T. M., Halabisky, B., Wes, P., Ransohoff, R. M., & Gan, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254268 · Cited by 268
Self-citationMicroglia in CNS development: Shaping the brain for the future
Mosser, C.-A., Baptista, S., Arnoux, I., & Audinat, E. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.002 · Cited by 268
“…and Alzheimer diseases, CX3CL1 or CX3CR1 deficiency leads to an increased production of proinflammatory mediators, such as interleukin-1b (IL-1b), and of reactive oxygen species (ROS) that trigger cell death (Cardona et al., 2006; Cho et al., 2011; Morganti et al., 2012; Sheridan and Murphy, 2013).”
Genetics of Amyotrophic Lateral Sclerosis
Ghasemi, M., & Brown, R. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024125 · Cited by 262
“It is an intriguing parallel that deletion of the mouse CX3CR1 gene also accelerates the course of SOD1G93A ALS in mice (Cardona et al. 2006).”
BackgroundQin, H., Yeh, W.-I., De Sarno, P., Holdbrooks, A. T., Liu, Y., Muldowney, M. T., Reynolds, S. L., Yanagisawa, L. L., Fox, T. H., Park, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117218109 · Cited by 263
“This is relevant because neuronal toxicity with synaptic dysfunction during EAE is associated with activated microglia (27, 28), and axonal transection in MS lesions is related to the abundance of activated macrophages (29).”
BackgroundChemokines and cytokines in neuroinflammation leading to neuropathic pain
Kiguchi, N., Kobayashi, Y., & Kishioka, S. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.007 · Cited by 262
“Interestingly, although fractalkine is characterized as both a pro-inflammatory and anti-inflammatory molecule [63,64], the activation of the fractalkine-CX3CR1 axis can attenuate peripheral nerve injury-induced neuropathic pain [62].”
BackgroundMolecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
Marchesi, F., Piemonti, L., Mantovani, A., & Allavena, P. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.001 · Cited by 260
Deczkowska, A., Matcovitch-Natan, O., Tsitsou-Kampeli, A., Ben-Hamo, S., Dvir-Szternfeld, R., Spinrad, A., Singer, O., David, E., Winter, D. R., Smith, L. K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00769-0 · Cited by 260
Schwab, J. M., Zhang, Y., Kopp, M. A., Brommer, B., & Popovich, P. G. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.023 · Cited by 260
“As a consequence of SCI and subsequent neurodegeneration, such control is lost and microglia become activated (Cardona et al., 2006; Meuth et al., 2008).”
BackgroundRegion‐specific expression of immunoregulatory proteins on microglia in the healthy CNS
de Haas, A. H., Boddeke, H. W. G. M., & Biber, K. (2008) · Glia · doi:10.1002/glia.20663 · Cited by 257
“…responses to CNS injury is strongly corroborated by recent in vivo studies impeding in microglia activity (Boillee et al., 2006; Bye et al., 2007; Cardona et al., 2006; El Khoury et al., 2007; Lalancette-Hebert et al., 2007; Neumann and Takahashi, 2007; Streit, 2006; Turrin and Rivest, 2006; van…”
BackgroundMicroglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes
Mecca, C., Giambanco, I., Donato, R., & Arcuri, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010318 · Cited by 258
“Previous studies on different animal models of neurodegeneration, showed that the loss of microglia-neuron relationships consequent to CX3CL1-CX3CR1 signal destruction, results in a greater neurotoxic activity of the microglia and an aggravation of disease [144].”
BackgroundResultInfluentialCellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
More, S. V., Kumar, H., Kim, I. S., Song, S.-Y., & Choi, D.-K. (2013) · Mediators of Inflammation · doi:10.1155/2013/952375 · Cited by 258
“Membrane-bound neuronal inhibitory signals consist of several molecules from the immunoglobulin superfamily including CD200 [50], CD22, and CD47, which are expressed or secreted by neurons that bind to receptors on microglia [48, 51, 52].”
BackgroundShaping Neuronal Fate: Functional Heterogeneity of Direct Microglia-Neuron Interactions
Cserép, C., Pósfai, B., & Dénes, Á. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.007 · Cited by 256
Peng, B., Xiao, J., Wang, K., So, K.-F., Tipoe, G. L., & Lin, B. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5200-13.2014 · Cited by 255
“DOI:10.1523/JNEUROSCI.5200-13.2014 Copyright © 2014 the authors 0270-6474/14/348139-12$15.00/0 survival (Meucci et al., 2000; Cardona et al., 2006).”
BackgroundInfluentialLipid and Lipoprotein Metabolism in Microglia
Loving, B. A., & Bruce, K. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00393 · Cited by 255
“The expression of the chemokine fractalkine (CX3CL1), a strong microglial chemoattractant and whose receptor in the CNS is expressed solely in microglia, is up-regulated in neurons during development (Harrison et al., 1998; Jung et al., 2000; Cardona et al., 2006; Liang et al., 2009).”
BackgroundOlah, M., Biber, K., Vinet, J., & W.G.M. Boddeke, H. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794488575 · Cited by 254
“These neuronal signaling molecules and their receptors on microglia have an established role in certain animal models [29, 30], but their potential contribution to shaping the microglial phenotype under physiological conditions still has to be firmly established.”
BackgroundSierra, A., Beccari, S., Diaz-Aparicio, I., Encinas, J. M., Comeau, S., & Tremblay, M.-È. (2014) · Neural Plasticity · doi:10.1155/2014/610343 · Cited by 251
“For instance, both microglia and neurons overexpress CHOP (C/EBP homologous protein), a transcription factor which is activated during ER stress in human patients and mouse models of ALS [114].”
BackgroundInfluentialCerbai, F., Lana, D., Nosi, D., Petkova-Kirova, P., Zecchi, S., Brothers, H. M., Wenk, G. L., & Giovannini, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045250 · Cited by 251
“[10,22,23], often contained neuronal debris within their cytoplasm, consistent with their scavenging activity of dying neurons.”
BackgroundThe role of microglia and myeloid immune cells in acute cerebral ischemia
Benakis, C., Garcia-Bonilla, L., Iadecola, C., & Anrather, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00461 · Cited by 248
“…delivery of CX3CL1 at the time of MCA occlusion decreased infarct volumes (Cipriani et al., 2011), suggesting that CX3CL1 acts on microglia to reduce their activation state and inhibit the release of inflammatory cytokines (Zujovic et al., 2000; Cardona et al., 2006; Biber et al., 2007).”
BackgroundCarroll, J. C., Iba, M., Bangasser, D. A., Valentino, R. J., James, M. J., Brunden, K. R., Lee, V. M.-Y., & Trojanowski, J. Q. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3836-11.2011 · Cited by 251
Karlmark, K. R., Zimmermann, H. W., Roderburg, C., Gassler, N., Wasmuth, H. E., Luedde, T., Trautwein, C., & Tacke, F. (2010) · Hepatology · doi:10.1002/hep.23894 · Cited by 249
Neumann, H., & Takahashi, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.032 · Cited by 249
Granado, N., Ortiz, O., Suarez, L. M., Martin, E. D., Cena, V., Solis, J. M., & Moratalla, R. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm026 · Cited by 249
Noninvasive Molecular Imaging of Neuroinflammation
Jacobs, A. H., Tavitian, B., & the INMiND consortium (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.53 · Cited by 245
“Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1393–1415; doi:10.1038/jcbfm.2012.53; published online 2 May 2012 Keywords: Alzheimer’s disease; cerebral ischemia; inflammation; multiple sclerosis; microglia; molecular imaging”
BackgroundInfluentialThe Ischemic Environment Drives Microglia and Macrophage Function
Fumagalli, S., Perego, C., Pischiutta, F., Zanier, E. R., & De Simoni, M.-G. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00081 · Cited by 242
“ALS 15–20 weeks No ↓ neuronal cell density, ↓ motor function, ↓ survival (178)”
BackgroundJurgens, H. A., Amancherla, K., & Johnson, R. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6389-11.2012 · Cited by 243
“Immunomodulatory factors CD200 and CX3CL1 are constitutively expressed in the brain and play an important role in downregulating inflammation and microglial activation during aging, stress and disease (Hoek et al., 2000; Cardona et al., 2006; Frank et al., 2007; Wynne et al., 2010; Jurgens and Johnson, 2012).”
BackgroundNeurosteroids as regulators of neuroinflammation
Yilmaz, C., Karali, K., Fodelianaki, G., Gravanis, A., Chavakis, T., Charalampopoulos, I., & Alexaki, V. I. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100788 · Cited by 213
“On the other hand, microglia might also play a protective role supporting neuronal survival, since loss of the fractalkine receptor CX3CR1, through which microglia interact with neurons (Sheridan and Murphy, 2013), dysregulates microglial responses and augments LPS-induced toxicity and neurodegeneration in the SN foll…”
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease
Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., & Bickford, P. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-9 · Cited by 241
“CX3CL1 has an essential role in protecting the brain from a dysregulated microglial response that leads to neurotoxicity [12].”
InfluentialMicroglia Modulate Hippocampal Neural Precursor Activity in Response to Exercise and Aging
Vukovic, J., Colditz, M. J., Blackmore, D. G., Ruitenberg, M. J., & Bartlett, P. F. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5925-11.2012 · Cited by 241
“Microglia-mediated neural precursor activation is dependent on CX3CL1 signaling As previous studies have indicated a key role for CX3CR1 in regulating microglial activation status (Mizuno et al., 2003; Cardona et al., 2006), we assessed whether signaling through this chemokine receptor could be responsible for the inf…”
BackgroundInfluentialBrain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
Uemura, M. T., Maki, T., Ihara, M., Lee, V. M. Y., & Trojanowski, J. Q. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00080 · Cited by 237
“, 2016), both of which has shown promote anti-inflammatory microglial phenotype in mouse models (Cardona et al., 2006; Fu et al., 2016).”
BackgroundHow microglia sense and regulate neuronal activity
Umpierre, A. D., & Wu, L. (2021) · Glia · doi:10.1002/glia.23961 · Cited by 237
“In disease contexts, loss of microglial CX3CR1 exacerbates neuronal cell death or enhances other cardinal features of neuropathology (Cardona et al., 2006).”
BackgroundCurrent status of chemokines in the adult CNS
Réaux-Le Goazigo, A., Van Steenwinckel, J., Rostène, W., & Mélik Parsadaniantz, S. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.001 · Cited by 236
“These data support the hypothesis that an increase in CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists may increase neuronal vulnerability (Cardona et al., 2006).”
BackgroundInfluentialAdult neurogenesis, glia, and the extracellular matrix
Cope, E. C., & Gould, E. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.023 · Cited by 236
“One mechanism by which new neurons regulate the neurotoxic effects of microglia is through the binding of the neuronal chemokine fractalkine to its microglial receptor Cx3cr1 (Cardona et al., 2006).”
Morris, G. P., Clark, I. A., Zinn, R., & Vissel, B. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.07.002 · Cited by 236
“Neurons suppress the activation of microglia via the CX3C-chemokine ligand 1 (CX3CL1/fractalkine), and its cognate receptor on microglia CX3CR1 (Cardona et al., 2006; Lyons et al., 2009).”
BackgroundInfluentialNeurodegeneration by Activation of the Microglial Complement-Phagosome Pathway
Bodea, L.-G., Wang, Y., Linnartz-Gerlach, B., Kopatz, J., Sinkkonen, L., Musgrove, R., Kaoma, T., Muller, A., Vallar, L., Di Monte, D. A., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5002-13.2014 · Cited by 234
“For the repeated treatment, the protocol from Cardona et al. (2006) was adapted.”
MethodInflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders
Schwab, C., & McGeer, P. L. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13402 · Cited by 234
“Its receptor is expressed exclusively by microglia [12].”
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 233
“CX3CL1, also termed fractalkine, is expressed by neurons, whereas its receptor, CX3CR1, is predominantly expressed by microglia [131, 132].”
BackgroundThe Involvement and Therapy Target of Immune Cells After Ischemic Stroke
Jian, Z., Liu, R., Zhu, X., Smerin, D., Zhong, Y., Gu, L., Fang, W., & Xiong, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02167 · Cited by 233
“The increase of soluble CX3CL1 enhances the inflammatory signals of microglia and macrophages expressing CX3CR1, leading to increased release of toxic cytokines and oxidative metabolites (95).”
BackgroundIsolation of murine microglial cells for RNA analysis or flow cytometry
Cardona, A. E., Huang, D., Sasse, M. E., & Ransohoff, R. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.327 · Cited by 236
“CX3CR1 expression is confined to microglial cells and CX3CR1/FKN have been attributed roles of neuroprotection by tonically inhibiting microglial neurotoxicity and recruiting regulatory natural killer cells during experimental allergic encephalomyeliti”
BackgroundSelf-citationMicroglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission
Marinelli, S., Basilico, B., Marrone, M. C., & Ragozzino, D. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.017 · Cited by 233
Absence of CX3CR1 impairs the internalization of Tau by microglia
Bolós, M., Llorens-Martín, M., Perea, J. R., Jurado-Arjona, J., Rábano, A., Hernández, F., & Avila, J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0200-1 · Cited by 231
“The binding of CX3CL1 to CX3CR1 maintains microglia in an “off” state [12], thereby inhibiting the release of proinflammatory cytokines [13, 14].”
BackgroundRos-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231
“Saijo K, et al. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death.”
BackgroundAge related macular degeneration and drusen: Neuroinflammation in the retina
Buschini, E., Piras, A., Nuzzi, R., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.011 · Cited by 230
Mandler, M., Valera, E., Rockenstein, E., Weninger, H., Patrick, C., Adame, A., Santic, R., Meindl, S., Vigl, B., Smrzka, O., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1256-4 · Cited by 229
Microglia Play an Active Role in Obesity-Associated Cognitive Decline
Cope, E. C., LaMarca, E. A., Monari, P. K., Olson, L. B., Martinez, S., Zych, A. D., Katchur, N. J., & Gould, E. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0789-18.2018 · Cited by 219
“…literature has conflicting evidence as to whether Cx3cr1 deficiency increases or reduces microglial activation under neuroinflammatory conditions (Cardona et al., 2006; Lee et al., 2010; Lauro et al., 2015), although our data suggest that Cx3cr1 deficiency is protective against…”
BackgroundProtracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge
Wynne, A. M., Henry, C. J., Huang, Y., Cleland, A., & Godbout, J. P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.05.011 · Cited by 224
“Injection of microglia isolated from LPS-treated CX3CR1 / mice into the brain of a wildtype mouse caused neuronal cell death, which was blocked by co-injection of IL-1 receptor antagonist (Cardona et al., 2006).”
InfluentialA Quantitative Framework to Evaluate Modeling of Cortical Development by Neural Stem Cells
Stein, J. L., de la Torre-Ubieta, L., Tian, Y., Parikshak, N. N., Hernández, I. A., Marchetto, M. C., Baker, D. K., Lu, D., Hinman, C. R., Lowe, J. K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.035 · Cited by 201
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.